Procedure
PRP group
PRP group is a medical procedure with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
50%
Ph phase_4
1
25%
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(1)
Other(1)
Detailed Status
Enrolling by invitation2
unknown1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)
Trials by Status
enrolling_by_invitation250%
unknown125%
completed125%
Recent Activity
0 active trials
Showing 4 of 4
enrolling_by_invitationphase_4
Use of PRP for the Healing of Grade III Ulcers
NCT07255391
enrolling_by_invitationnot_applicable
Platelet Rich Plasma in the Prevention of Adhesion Reformation
NCT06608407
unknownphase_2
Intravitreal Bevacizumab vs Laser vs Combination of Bevacizumab and Modified Laser in PDR
NCT04800679
completednot_applicable
Use of Platelet-rich Plasma in Second-degree Superficial Burns
NCT04276818
Clinical Trials (4)
Showing 4 of 4 trials
NCT07255391Phase 4
Use of PRP for the Healing of Grade III Ulcers
NCT06608407Not Applicable
Platelet Rich Plasma in the Prevention of Adhesion Reformation
NCT04800679Phase 2
Intravitreal Bevacizumab vs Laser vs Combination of Bevacizumab and Modified Laser in PDR
NCT04276818Not Applicable
Use of Platelet-rich Plasma in Second-degree Superficial Burns
All 4 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 4